RESUMO
Glass fiber-reinforced polymer (GFRP) of high performance, as a relatively ideal partial or complete substitute for steel, could increase the possibility of adapting structures to changes in harsh weather environments. While GFRP is combined with concrete in the form of bars, the mechanical characteristics of GFRP cause the bonding behavior to differ significantly from that of steel-reinforced members. In this paper, a central pull-out test was applied, according to ACI440.3R-04, to analyze the influence of the deformation characteristics of GFRP bars on bonding failure. The bond-slip curves of the GFRP bars with different deformation coefficients exhibited distinct four-stage processes. Increasing the deformation coefficient of the GFRP bars is able to significantly improve the bond strength between the GFRP bars and the concrete. However, while both the deformation coefficient and concrete strength of the GFRP bars were increased, the bond failure mode of the composite member was more likely to be changed from ductile to brittle. The results show members with larger deformation coefficients and moderate concrete grades, which generally have excellent mechanical and engineering properties. By comparing with the existing bond and slip constitutive models, it was found that the proposed curve prediction model was able to well match the engineering performance of GFRP bars with different deformation coefficients. Meanwhile, due to its high practicality, a four-fold model characterizing representative stress for the bond-slip behavior was recommended in order to predict the performance of the GFRP bars.
RESUMO
BACKGROUND: A growing number of boron-containing compounds exhibit many important biological activities; of particular interest are the α-amino acid borinic derivatives with activity in the CNS. A validated, sensitive and specific UPLC-MS/MS technique for quantification of the diphenylboroxazolidones of glycine (DBPX-gly), L-aspartate (DPBX-L-asp) and L-glutamate (DPBX-L-glu) in dried blood spots (DBSs) is presented. RESULTS: The most intense signal corresponds to compounds with (11)B. The extraction procedure was liquid elution of 3.2-mm punched DBSs with acetonitrile:aqueous formic acid 0.1% (80:20 v/v). Assays proved to be linear, falling accurately and precisely within the range of 0.3-50 µg/ml for DPBX-L-asp and DPBX-L-glu and 0.1-5 µg/ml for DBPX-gly. Chromatograms exhibit clean 2.0-min running time peaks and S/N ratios for the LLOQ were approximately 15:1. The technique was used to evaluate the pharmacokinetics of the molecules and to correlate these with timecourse toxic effects. CONCLUSION: DBSs represent an advantage for the collection of small volumes of samples, and also in terms of processing and storage. UPLC-MS/MS allow us not only to identify the isotopic pattern of boron in DBPX, but also to quantify them with accuracy and specificity. Pharmacokinetics of these molecules exhibit a high apparent volume of distribution; it suggests a preference of DPBX-amino acids for fatty tissues such as the CNS.
